A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

NCT05678010 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Metastatic Solid Tumor
Solid Carcinoma
Solid Tumor, Adult
Metastatic Tumor
Metastatic Cancer

Interventions

DRUG: AZD1390
RADIATION: Stereotactic Body Radiotherapy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]